Avantax Planning Partners, Inc. Hcw Biologics Inc. Transaction History
Avantax Planning Partners, Inc.
- $2.78 Billion
- Q3 2024
A detailed history of Avantax Planning Partners, Inc. transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 279,541 shares of HCWB stock, worth $265,563. This represents 0.01% of its overall portfolio holdings.
Number of Shares
279,541
Previous 279,541
-0.0%
Holding current value
$265,563
Previous $181,000
17.13%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding HCWB
# of Institutions
17Shares Held
1.16MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA183KShares$174,0960.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$171,7690.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$125,3900.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX84.7KShares$80,4650.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$71,3600.03% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $34M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...